Conduit Pharmaceuticals I... (CDT)
NASDAQ: CDT
· Real-Time Price · USD
1.62
-0.05 (-2.99%)
At close: Aug 15, 2025, 3:59 PM
1.71
5.56%
After-hours: Aug 15, 2025, 07:24 PM EDT
Conduit Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 29, 2025 | Mar 30, 2025 | Dec 31, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Net Income | 104.08M | 37.69M | -17.82M | -13.64M | -5.19M | -2.31M | -908K | -5.76M | -7.54M | -5.15M | -3.29M | -217.63K | -424.54K | -307K |
Depreciation & Amortization | 62.3M | 53.75M | 50.96M | 50.5M | 50.5M | 26.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 15.32M | 8.98M | 1.63M | 1.46M | 1.11M | 630K | 199K | 10K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -1.46M | -1.75M | -1.37M | -3.8M | -3.33M | -2.1M | -1.94M | 3.31M | 2.11M | 1.35M | 873.84K | 46.84K | -246.56K | -432.64K |
Other Non-Cash Items | -96.28M | -76.06M | 6.3M | 3.55M | -4.22M | -5.43M | -6.79M | -2.88M | 2.04M | 711.5K | 578.5K | -785.5K | -175.59K | 16K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.76M | -1.15M | -142K | -1.95M | -2.05M | -1.72M | -1.47M | 3.57M | 2.11M | 1.35M | 805.61K | -21.39K | -314.79K | -497K |
Operating Cash Flow | 83.66M | 116K | -9.68M | -10.67M | -10.46M | -9.37M | -8.98M | -5.06M | -3.39M | -3.09M | -1.9M | -1.02M | -914.91K | -788K |
Capital Expenditures | -57.39M | -32.25M | -24.3M | -24.3M | -24.26M | -24.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | -288.53M | -288.53M | -296.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | 490K | n/a | n/a | -980K | -100.06K | 155.4K | n/a | n/a | -389.94K | -155.4K | -134.9M | -134.9M | -134.9M | -134.9M |
Sales Maturities Of Investments | -191K | 85K | 85K | n/a | -114.58M | -114.03M | n/a | n/a | 114.86M | 114.03M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 401.29M | 401.06M | 401.01M | 25.71M | 561K | 594.76K | -113.58M | -114.14M | -114.36M | -114.17M | -54K | n/a | n/a | n/a |
Investing Cash Flow | -49.14M | -24.22M | -24.23M | -23.82M | -138.16M | -137.53M | -113.58M | -114.14M | 107K | -297K | -134.95M | -134.9M | -134.9M | -134.9M |
Debt Repayment | 316K | 316K | 2.45M | -6.75M | -6.96M | -6.95M | -4.73M | 4.18M | 2.65M | 2.64M | 422K | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | 114.07M | n/a | n/a | n/a | -114.07M | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -12.18M | -10.17M | -10.23M | -4.11M | -2.08M | -2.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -109.96M | -92.43M | -57.52M | -55.56M | -48.95M | 65.2M | 130.99M | 122.92M | 114.27M | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | -110.25M | -90.72M | -58.87M | -63.49M | 59.51M | 59.4M | 126.56M | 127.91M | 3.16M | 3.15M | 1.72M | 789K | 789K | 789K |
Net Cash Flow | -68.48M | -112.59M | -3.67M | -8.57M | -58.76K | 1.84M | 3.88M | 7.92M | -559.93K | -956.6K | -665.38K | -283.08K | -173.47K | -46.55K |
Free Cash Flow | 26.26M | -32.14M | -33.98M | -34.97M | -34.72M | -33.62M | -8.98M | -5.06M | -3.39M | -3.09M | -1.9M | -1.02M | -914.91K | -788K |